These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 37266763)

  • 1. Orally Induced High Serum Level of Trimethylamine N-oxide Worsened Glial Reaction and Neuroinflammation on MPTP-Induced Acute Parkinson's Disease Model Mice.
    Qiao CM; Quan W; Zhou Y; Niu GY; Hong H; Wu J; Zhao LP; Li T; Cui C; Zhao WJ; Shen YQ
    Mol Neurobiol; 2023 Sep; 60(9):5137-5154. PubMed ID: 37266763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson's Disease.
    Quan W; Qiao CM; Niu GY; Wu J; Zhao LP; Cui C; Zhao WJ; Shen YQ
    Brain Sci; 2023 May; 13(5):. PubMed ID: 37239262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
    Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
    J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
    Zhang J; Wang M; Zhao Y; Zhang Y; Gao Y; Zhang X; Yang G
    Neurosci Lett; 2022 Jun; 781():136669. PubMed ID: 35490905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson's disease mouse models.
    Zhang F; Pan L; Lian C; Xu Z; Chen H; Lai W; Liang X; Liu Q; Wu H; Wang Y; Zhang P; Zhang G; Liu Z
    Brain Res Bull; 2024 Aug; 214():110989. PubMed ID: 38825252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
    Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
    J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of CDNF by AAV-mediated gene transfer protects dopamine neurons and regulates ER stress and inflammation in an acute MPTP mouse model of Parkinson's disease.
    Nam J; Richie CT; Harvey BK; Voutilainen MH
    Sci Rep; 2024 Jul; 14(1):16487. PubMed ID: 39019902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.
    Cheng YY; Chen BY; Bian GL; Ding YX; Chen LW
    Mol Neurobiol; 2022 Apr; 59(4):2642-2655. PubMed ID: 35142987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses.
    Calvello R; Cianciulli A; Nicolardi G; De Nuccio F; Giannotti L; Salvatore R; Porro C; Trotta T; Panaro MA; Lofrumento DD
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):327-339. PubMed ID: 27987058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease.
    Wang D; Gao H; Qin Q; Li J; Zhao J; Qu Y; Li J; Xiong Y; Min Z; Mao Z; Xue Z
    J Transl Med; 2024 Jan; 22(1):63. PubMed ID: 38229084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.
    Hu ZL; Sun T; Lu M; Ding JH; Du RH; Hu G
    Brain Behav Immun; 2019 Oct; 81():509-522. PubMed ID: 31288070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
    Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMAL1 regulation of microglia-mediated neuroinflammation in MPTP-induced Parkinson's disease mouse model.
    Liu WW; Wei SZ; Huang GD; Liu LB; Gu C; Shen Y; Wang XH; Xia ST; Xie AM; Hu LF; Wang F; Liu CF
    FASEB J; 2020 May; 34(5):6570-6581. PubMed ID: 32246801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease.
    Liang Y; Chen C; Xia B; Wu W; Tang J; Chen Q; Tang L; Yang H; Zhang Z; Lu Y; Yang Y; Zhao Y
    Biomed Res Int; 2019; 2019():4379639. PubMed ID: 30834264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.